Psychopharmacology of child and adolescent anxiety disorders

Psychiatric Annals

Volumn 33, Issue 4, 2003, Pages 273-278

  Rosenberg, David R ^a   Banerjee, Preeya ^a   Ivey, Jennifer L ^a   Lorch, Elisa R ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ANXIETY DISORDER; BIPOLAR DISORDER; CHILD PSYCHIATRY; HUMAN; MAJOR DEPRESSION; OBSESSIVE COMPULSIVE DISORDER; PANIC; PHOBIA; POSTTRAUMATIC STRESS DISORDER; PRESCRIPTION; REVIEW; SEPARATION ANXIETY; SOCIAL PHOBIA; STREPTOCOCCUS INFECTION;

EID: 1942435573     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-20030401-08     Document Type: Review

References (42)

1. Labellarte MJ, Ginsburg GS, Walkup JT, Riddle MA. The treatment of anxiety disorders in children and adolescents. Biol Psychiatry. 1999;46:1567-1578.
2. Cartwright C, Hollander E. SSRIs in the treatment of obsessive-compulsive disorder. Depress Anxiety. 1998;8(suppl 1):105-113.
3. DeVeaugh-Geiss J. Pharmacologic therapy of obsessive compulsive disorder. Adv Pharmacol. 1994;30:35-52.
4. Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. Arch Gen Psychiatry. 1995;52:53-60.
5. Mundo E, Bianchi L, Bellodi L. Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study. J Clin Psychopharmacol. 1997;17:267-271.
6. Freeman CPL, Trimble MR, Deakin JFW, Stokes TM, Ashford JJ. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison. J Clin Psychiatry. 1994;55:7e 301-305.
7. Pigott TA, Pato MT, Bernstein SE, et al. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder: behavioral and biological results. Arch Gen Psychiatry. 1990;47:926-932.
8. March J, Frances A, Kahn D, Carpenter D. Treatment of obsessive-compulsive disorder. The Expert Consensus Panel for obsessive-compulsive disorder. J Clin Psychiatry. 1997;58(suppl 4):2-72.
9. DeVeaugh-Geiss J, Moroz G, Biederman J, et al. Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder - a multicenter trial. J Am Acad Child Adolesc Psychiatry. 1992;31:45-49.
10. Riddle MA, Reeve EA, Yaryura-Tobias JA, et al. Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial. J Am Acad Child Adolesc Psychiatry. 2001;40: 222-229.
11. March JS, Biederman J, Wolkow R, et al. Sertraline in children and adolescents with obsessive compulsive disorder: a multicenter double-blind, placebo-controlled study. JAMA. 1998;280:1752-1756.
12. Geller D, Coffey B, Rosenberg D, Carpenter D, Pauls D. Recent advances in pediatric obsessive compulsive and Tourette's disorders. Scientific Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry. 2001;331:68-69.
13. Wagner KD, Emslie G, Birmaher B, et al. Safety of paroxetine in the treatment of children and adolescents with OCD. J Child Adolesc Psychopharmacol. 2000;10(4):240-241.
14. Emslie G, Judge R. Tricyclic antidepressants and selective serotonin reuptake inhibitors: use during pregnancy, in children/adolescents and in the elderly. Acta Psychiatr Scand Suppl. 2000;403:26-34.
15. Walkup JT, Reeve E, Yaryura-Tobias J, et al. Fluvoxamine for childhood obsessive compulsive disorder: long-term treatment [abstract]. Presented at: 38th Annual Meeting of the National Institute of Mental Health, New Clinical Drug Evaluation Unit Program; June 10-13, 1998; Boca Raton, Fla.
16. Findling RL, Reed MD, Myers C, et al. Paroxetine pharmacokinetics in depressed children and adolescents. J Am Acad Child Adolesc Psychiatry. 1999;38:952-959.
17. Findling RL, Preskorn SH, Marcus RN, et al. Nefazodone pharmacokinetics in depressed children and adolescents. J Am Acad Child Adolesc Psychiatry 2000;39:1008-1016.
18. Goodman WK, McDougle CJ, Price LH. Pharmacotherapy of obsessive compulsive disorder. J Clin Psychiatry. 1992;53(suppl): 29-37.
19. Pigott TA, Pato MT, L'Heureux F, et al. A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive compulsive disorder. J Clin Psychopharmacol. 1991;11:242-248.
20. Pigott TA, L'Heureux F, Hill JL, Bihari K, Bernstein SE, Murphy DL. A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive compulsive disorder. J Clin Psychopharmacol. 1992;12:11-18.
21. Pigott TA, L'Heureux F, Rubenstein CS, Hill JL, Murphy DL. A controlled trial of clonazepam augmentation in OCD patients treated with clomipramine or fluoxetine. Presented at: 145th Annual Meeting of the American Psychiatric Association; May 2-7, 1992:82; Washington, DC.
22. Pigott TA, L'Heureux F, Rubenstein CS, Bernstein SE, Hill JL, Murphy DL. A double-blind, placebo controlled study of trazodone in patients with obsessive-compulsive disorder. J Clin Psychopharmacol. 1992;12: 156-162.
23. McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH. Haloperidol addition in fluvoxamine-refractory obsessive compulsive disorder. Arch Gen Psychiatry. 1994;51:302-308.
24. McDougle CJ, Goodman WK, Price LH, et al. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder. Am J Psychiatry. 1990;147:652-654.
25. McDougle CJ, Epperson CN, Pelton GH, Wasylink S, Price LH. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry. 2000;57:794-801.
26. Fitzgerald KD, Stewart CM, Tawile V, Rosenberg DR. Risperidone augmentation of serotonin reuptake inhibitor treatment of pediatric obsessive compulsive disorder. J Child Adolesc Psychopharmacol. 1999;9:115-123.
27. Figueroa Y, Rosenberg DR, Birmaher B, Keshavan MS. Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents. J Child Adolesc Psychopharmacol. 1998;8:61-67.
28. Simeon JG, Thatte S, Wiggins D. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination. Psychopharmacol Bull. 1990;26:285-290.
29. March JS, Mulle K. OCD in Children and Adolescents: A Cognitive Behavioral Treatment Manual. New York, NY: Guilford; 1998.
30. Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998;155:264-271.
31. Leonard HL, Swedo SE, Garvey M, et al. Postinfectious and other forms of obsessive-compulsive disorder. Child Adolesc Psychiatr Clin N Am. 1999;8:497-511.
32. Keller M, Ryan ND, Strober M, et al. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry. 2001;40:762-772.
33. Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. N Engl J Med. 2001;344:1279-1285.
34. Klein DF, ed. Diagnosis and Drug Treatment of Psychiatric Disorders: Adults and Children. 2nd ed. Baltimore, Md: Willliams & Wilkins; 1980.
35. Klein R, Koplewicz H, Kanner A. Imipramine treatment of children with separation anxiety disorder. J Am Acad Child Adolesc Psychiatry. 1992;31:21-28.
36. Bernstein GA, Borchardt CM, Perwien AR, et al. Imipramine plus cognitive-behavioral therapy in the treatment of school refusal. J Am Acad Child Adolesc Psychiatry. 2000;39:276-283.
37. Berney T, Kolvin I, Bhate SR, et al. School phobia: a therapeutic trial with clomipramine and short-term outcome. Br J Psychiatry. 1981;138:110-118.
38. Graae F, Milner J, Rizzotto L, Klein RG. Clonazepam in childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry. 1994;33:372-376.
39. Gutgesell H, Atkins D, Barst R, et al. AHA scientific statement: cardiovascular monitoring of children and adolescents receiving psychotropic drugs. J Am Acad Child Adolesc Psychiatry. 1999;38:1047-1050.
40. Renaud J, Birmaher B, Wassick SC, Bridge J. Use of selective serotonin reuptake inhibitors for the treatment of childhood panic disorder: a pilot study. J Child Adolesc Psychopharmacol. 1999;9:73-83.
41. Black B, Leonard HL, Rapoport JL. Specific phobia, panic disorder, social phobia, and selective mutism. In: Weiner JM, ed. Textbook of Child and Adolescent Psychiatry. Washington, DC: American Psychiatric Press; 1997.
42. Balon R. Fluvoxamine for phobia of storms. Acta Psychiatr Scand. 1999;100:244-245.